KCKaroline Rodrigues Campos

Karoline Rodrigues Campos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karoline Rodrigues Campos has a total of 133 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Outbreak of NDM-1-Producing Acinetobacter baumannii CC2 in Southeastern Brazil: genomic epidemiology and environmental contamination

    by Carlos Henrique Camargo, Amanda Yaeko Yamada, Hercília Borges, Cláudio Tavares Sacchi, Karoline Rodrigues Campos, Cinara Rodrigues Oliveira, Leandro de Lane Moraes, Fernanda Matsiko Inoue, Carlos Roberto Veiga Kiffer, Jussimara Monteiro

  • Stepwise Evolution of Triple Antimicrobial Resistance in Neisseria meningitidis

    by José Eduardo O Marín, María Jose L Boza, Carlos Henrique Camargo, Karoline R Campos, Marlon Benedito N Santos, Amanda Y Yamada, Claudio T Sacchi, Ana Paula S Lemos

    Background: Invasive meningococcal disease is a rapidly progressive infection with high mortality, for which effective antimicrobial therapy and chemoprophylaxis are essential. During national surveillance in El Salvador, invasive Neisseria meningitidis serogroup Y isolates with resistance to first-line agents were identified, prompting further investigation. Methods: Ten invasive N. meningitidis serogroup Y isolates, selected for dual resistance to penicillin and ciprofloxacin and collected between 2020 and 2025 by the National Public Health Laboratory of El Salvador, were analyzed at the Adolfo Lutz Institute, São Paulo, Brazil. Antimicrobial susceptibility testing was performed by minimum inhibitory concentration determination, and resistance mechanisms were characterized by whole-genome sequencing. Results: All isolates were resistant to penicillin and ciprofloxacin. Genomic analysis showed that penicillin resistance was mediated by acquisition of the β-lactamase gene blaROB-1, while ciprofloxacin resistance was associated with a threonine-to-isoleucine substitution at position 91 of DNA gyrase (gyrA T91I). Two isolates additionally carried the tetB gene, defining a triple-resistance phenotype. These isolates exhibited markedly elevated tetracycline minimum inhibitory concentrations (6 μg/mL), approximately 40-fold higher than those observed in tetracycline-susceptible isolates. Increased MICs were also observed for minocycline and doxycycline, whereas susceptibility to newer tetracycline derivatives, including tigecycline and eravacycline, was preserved. All isolates belonged to sequence type 3587 within clonal complex 23. Conclusions: We report the first identification of N. meningitidis with concurrent resistance to penicillin, ciprofloxacin, and tetracycline, mediated by blaROB-1, gyrA T91I, and tetB, representing a critical escalation in meningococcal antimicrobial resistance.

  • Unveiling the genomic and phenotypic landscape of Acinetobacter species from different environmental sources in Brazil

    by Amanda Yaeko Yamada, Anna Luiza Bauer Canellas, Matheus Nunes Diniz, Pedro Smith Pereira Ferraro, Daniel de Sena Miranda, Ana Beatriz Nascimento Costa, Marlon Benedito Nascimento Santos, Karoline Rodrigues Campos, Claudio Tavares Sacchi, Beatriz Balthazar Abdon, et al.

    This study aimed to investigate the diversity of Acinetobacter spp. isolated from aquatic environments along the Brazilian coast, with a focus on environmental reservoirs of clinically relevant resistance genes. Twenty-three Acinetobacter isolates were recovered from marine animals, floating plastic, and surface water samples collected in two contrasting Brazilian regions: the heavily polluted Guanabara Bay (Rio de Janeiro) and the pristine Fernando de Noronha Archipelago (Pernambuco). Seven species were identified, with A. venetianus (n = 13) and A. johnsonii (n = 4) being the most frequent. Two A. johnsonii isolates carried the metallo-β-lactamase gene blaNDM-1, along with resistance to fluoroquinolones and carbapenems. Resistance to polymyxins and aminoglycosides was also observed in A. haemolyticus, A. baumannii, and A. modestus. ApaI-PFGE dendrogram and phylogenetic analyses based on single nucleotide position (SNPs) revealed high genetic diversity, and global comparisons placed the environmental isolates in lineages distinct from those commonly associated with healthcare-associated infections. This study highlights the diversity of Acinetobacter spp. in aquatic environments and their potential role as reservoirs of clinically important resistance genes, including blaNDM-1. By uncovering resistance mechanisms in environmental Acinetobacter strains, this work reinforces the relevance of environmental surveillance for One Health initiatives, particularly in regions with significant anthropogenic impact.

  • Open Access

    Oropouche Virus Outbreak in Southeast, Brazil: Expanding Beyond the Amazonian Endemic Region

    by Edson Delatorre, Gabriela Mendonça de Colombo, Felipe Donateli Gatti, Anna Clara Gregório Có, Julia del Piero Pereira, Eric Arrivabene Tavares, Joana Zorzal Nodari, Agata Rossi, Suwellen Sardinha Dias de Azevedo, Cláudio Tavares Sacchi, et al.

    The Oropouche virus (OROV), historically endemic to the Amazon, has spread to nearly all Brazilian states in 2024, with Espírito Santo emerging as a significant transmission hotspot in the Atlantic Forest biome. We characterized the epidemiological factors driving OROV spread in non-endemic Southeast Brazil, analyzing environmental and agricultural conditions contributing to viral transmission. Samples from 29,000 suspected arbovirus-infected patients were tested by RT-qPCR for Dengue, Chikungunya, Zika, Mayaro, and Oropouche virus. Between March and June 2024, OROV cases in the state reached 339, demonstrating successful local transmission. Spatial analysis revealed that most cases clustered in municipalities with tropical climates and intensive cacao, robusta coffee, coconut, and pepper cultivation. Phylogenetic analysis identified the Espírito Santo OROV strains as part of the 2022-2024 Amazonian lineage. The rapid spread of OROV outside the Amazon highlights its adaptive potential and public health threat, emphasizing the need for enhanced surveillance and targeted control measures.


  • Open Access

    Genomic Characterization of a Clinical NDM-1-Producing Klebsiella michiganensis from Brazil

    by Amanda Yaeko Yamada, Andreia Rodrigues de Souza, Amanda Maria de Jesus Bertani, Karoline Rodrigues Campos, Claudio Tavares Sacchi, Denise Brandão de Assis, Enéas de Carvalho, Elizabeth Harummyy Takagi, Marcos Paulo Vieira Cunha, Monique Ribeiro Tiba-Casas, et al.

    Public health faces daily challenges due to increasing reports of pathogenic microorganisms with new antimicrobial resistance. Klebsiella michiganensis, an emerging pathogen, poses difficulty in its identification using conventional techniques. This study presents the first documented case of NDM-1-producing K. michiganensis in Brazil, identified as the new ST418. Initially, the isolate from a tracheal secretion was misidentified as K. oxytoca. However, accurate identification was achieved through ANI analyses. Whole-genome sequencing was conducted to characterize the genetic context of the resistance genes, to identify virulence factors, and to construct a phylogenetic tree. The blaNDM-1 gene was found to be harbored on an IncFIB plasmid approximately 112 kb in length, which was transferable in conjugation assays. The detection of carbapenem resistance genes in this species highlights the importance of public health vigilance, as it may serve as a reservoir and disseminator of significant resistance genes.


  • Open Access

    Polymyxin Resistance in Salmonella: Exploring Mutations and Genetic Determinants of Non-Human Isolates

    by Thais Vieira, Carla Adriana Dos Santos, Amanda Maria de Jesus Bertani, Gisele Lozano Costa, Karoline Rodrigues Campos, Cláudio Tavares Sacchi, Marcos Paulo Vieira Cunha, Eneas Carvalho, Alef Janguas da Costa, Jacqueline Boldrin de Paiva, et al.

    Until 2015, polymyxin resistance was primarily attributed to chromosomal mutations. However, with the first report of mobile colistin resistance (mcr-1) in commensal Escherichia coli from food animals in China, the landscape has changed. To evaluate the presence of polymyxin resistance in Salmonella spp., a drop screening test for colistin and polymyxin B was carried out on 1156 isolates of non-human origin (animals, food, and the environment), received in Brazil, between 2016 and 2021. Subsequently, 210 isolates with resistant results in the drop test were subjected to the gold-standard test (broth microdilution) for both colistin and polymyxin B. Whole-genome sequencing (WGS) of 102 resistant isolates was performed for a comprehensive analysis of associated genes. Surprisingly, none of the isolates resistant to colistin in the drop test harbored any of the mcr variants (mcr-1 to mcr-10). WGS identified that the most common mutations were found in pmrA (n= 22; T89S) and pmrB (n = 24; M15T, G73S, V74I, I83A, A111V). Other resistance determinants were also detected, such as the aac(6′)-Iaa gene in 72 isolates, while others carried beta-lactamase genes (blaTEM-1 blaCTX-M-2, blaCMY-2). Additionally, genes associated with fluoroquinolone resistance (qnrB19, qnrS1, oqxA/B) were detected in 11 isolates. Colistin and polymyxin B resistance were identified among Salmonella from non-human sources, but not associated with the mcr genes. Furthermore, the already-described mutations associated with polymyxin resistance were detected in only a small number of isolates, underscoring the need to explore and characterize unknown genes that contribute to resistance.


  • Molecular characterization and whole-genome sequencing of Corynebacterium diphtheriae causing skin lesion

    by Juliana Nunes Ramos, Max Roberto Batista Araújo, Lincoln Oliveira Sant’aNna, Sérgio Bokermann, Carlos Henrique Camargo, Fernanda Diniz Prates, Cláudio Tavares Sacchi, Verônica Viana Vieira, Karoline Rodrigues Campos, Marlon Benedito Nascimento Santos, et al.

    We present a case of skin lesion caused by nontoxigenic Corynebacterium diphtheriae. Genomic taxonomy analyses corroborated the preliminary identification provided by mass spectrometry. The strain showed a susceptible phenotype with increased exposure to penicillin, the first drug of choice for the treatment. An empty type 1 class integron carrying only the sul1 gene, which encodes sulfonamide resistance, was found flanked by transposases. Virulence factors involved in adherence and iron uptake, as well as the CRISPR-Cas system, were predicted. MLST analysis revealed the ST-681, previously reported in French Guiana, a European territory.


  • Open Access

    Technical comparison of MinIon and Illumina technologies for genotyping Chikungunya virus in clinical samples

    by Leandro Menezes de Souza, Isabelle Dias de Oliveira, Flávia Cristina Silva Sales, Antonio Charlys da Costa, Karoline Rodrigues Campos, Adriano Abbud, Juliana Mariotti Guerra, Cinthya dos Santos Cirqueira Borges, Carlos Pires Fernandes Júnior Takahashi, Leonardo José Tadeu de Araújo


  • Phenotypic and molecular characterization and complete genome sequence of a Corynebacterium diphtheriae strain isolated from cutaneous infection in an immunized individual

    by Max Roberto Batista Araújo, Juliana Nunes Ramos, Lincoln de Oliveira Sant’aNna, Sérgio Bokermann, Marlon Benedito Nascimento Santos, Ana Luiza Mattos-Guaraldi, Vasco Azevedo, Fernanda Diniz Prates, Diego Lucas Neres Rodrigues, Flávia Figueira Aburjaile, et al.

    Diphtheria is an infectious disease potentially fatal that constitutes a threat to global health security, with possible local and systemic manifestations that result mainly from the production of diphtheria toxin (DT). In the present work, we report a case of infection by Corynebacterium diphtheriae in a cutaneous lesion of a fully immunized individual and provided an analysis of the complete genome of the isolate. The clinical isolate was first identified by MALDI-TOF Mass Spectrometry. The commercial strip system and mPCR performed phenotypic and genotypic characterization, respectively. The antimicrobial susceptibility profile was determined by the disk diffusion method. Additionally, genomic DNA was sequenced and analyzed for species confirmation and sequence type (ST) determination. Detection of resistance and virulence genes was performed by comparisons against ResFinder and VFDB databases. The isolate was identified as a nontoxigenic C. diphtheriae biovar Gravis strain. Its genome presented a size of 2.46 Mbp and a G + C content of 53.5%. Ribosomal Multilocus Sequence Typing (rMLST) allowed the confirmation of species as C. diphtheriae with 100% identity. DDH in silico corroborated this identification. Moreover, MLST analyses revealed that the isolate belongs to ST-536. No resistance genes were predicted or mutations detected in antimicrobial-related genes. On the other hand, virulence genes, mostly involved in iron uptake and adherence, were found. Presently, we provided sufficient clinical data regarding the C. diphtheriae cutaneous infection in addition to the phenotypic and genomic data of the isolate. Our results indicate a possible circulation of ST-536 in Brazil, causing cutaneous infection. Considering that cases of C. diphtheriae infections, as well as diphtheria outbreaks, have still been reported in several regions of the world, studies focusing on taxonomic analyzes and predictions of resistance genes may help to improve the diagnosis and to monitor the propagation of resistant clones. In addition, they can contribute to understanding the association between variation in genetic factors and resistance to antimicrobials.


  • Open Access

    Genomics and Antimicrobial Susceptibility of Clinical Pseudomonas aeruginosa Isolates from Hospitals in Brazil

    by Carlos Henrique Camargo, Amanda Yaeko Yamada, Andreia Rodrigues de Souza, Marisa de Jesus de Castro Lima, Marcos Paulo Vieira Cunha, Pedro Smith Pereira Ferraro, Claudio Tavares Sacchi, Marlon Benedito Nascimento dos Santos, Karoline Rodrigues Campos, Monique Ribeiro Tiba-Casas, et al.

    Pseudomonas aeruginosa, an opportunistic pathogen causing infections in immunocompromised patients, usually shows pronounced antimicrobial resistance. In recent years, the frequency of carbapenemases in P. aeruginosa has decreased, which allows use of new beta-lactams/combinations in antimicrobial therapy. Therefore, the in vitro evaluation of these drugs in contemporary isolates is warranted. We evaluated the antimicrobial susceptibility and genomic aspects of 119 clinical P. aeruginosa isolates from 24 different hospitals in Brazil in 2021–2022. Identification was performed via MALDI-TOF-MS, and antimicrobial susceptibility was identified through broth microdilution, gradient tests, or disk diffusion. Whole-genome sequencing was carried out using NextSeq equipment. The most active drug was cefiderocol (100%), followed by ceftazidime–avibactam (94.1%), ceftolozane–tazobactam (92.4%), and imipenem–relebactam (81.5%). Imipenem susceptibility was detected in 59 isolates (49.6%), and the most active aminoglycoside was tobramycin, to which 99 (83.2%) isolates were susceptible. Seventy-one different sequence types (STs) were detected, including twelve new STs described herein. The acquired resistance genes blaCTX-M-2 and blaKPC-2 were identified in ten (8.4%) and two (1.7%) isolates, respectively. Several virulence genes (exoSTUY, toxA, aprA, lasA/B, plcH) were also identified. We found that new antimicrobials are effective against the diverse P. aeruginosa population that has been circulating in Brazilian hospitals in recent years.